Related references
Note: Only part of the references are listed.Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN projectaEuro
A. Kramar et al.
ANNALS OF ONCOLOGY (2015)
Association of HADHA with human RNA silencing machinery
Pavan Kumar Kakumani et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis
Hiromi I. Wettersten et al.
CANCER RESEARCH (2015)
Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA
Aik T. Ooi et al.
CLINICAL CANCER RESEARCH (2015)
Identification and validation of TGFBI as a promising prognosis marker of clear cell renal cell carcinoma
Souhil Lebdai et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma
L. Zhang et al.
CELL DEATH & DISEASE (2015)
The Changes of Lipid Metabolism in Advanced Renal Cell Carcinoma Patients Treated with Everolimus: A New Pharmacodynamic Marker?
Francesco Pantano et al.
PLOS ONE (2015)
Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma
Zuohui Zhao et al.
TUMOR BIOLOGY (2015)
Targeting prostate cancer cell metabolism: impact of hexokinase and CPT-1 enzymes
Rouhallah Najjar Sadeghi et al.
TUMOR BIOLOGY (2015)
Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation
J. J. Souchek et al.
BRITISH JOURNAL OF CANCER (2014)
Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling
A. Atrih et al.
BRITISH JOURNAL OF CANCER (2014)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Lysine Acetylation Activates 6-Phosphogluconate Dehydrogenase to Promote Tumor Growth
Changliang Shan et al.
MOLECULAR CELL (2014)
Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer
Julian Swierczynski et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma
Nicole M. A. White et al.
ONCOTARGET (2014)
Cellular Fatty Acid Metabolism and Cancer
Erin Currie et al.
CELL METABOLISM (2013)
Visceral Obesity and Risk of High Grade Disease in Clinical T1a Renal Cell Carcinoma
Yao Zhu et al.
JOURNAL OF UROLOGY (2013)
Reduction of fatty acid oxidation and responses to hypoxia correlate with the progression of de-differentiation in HCC
Masatake Tanaka et al.
MOLECULAR MEDICINE REPORTS (2013)
The expression of Eg5 predicts a poor outcome for patients with renal cell carcinoma
Dingqi Sun et al.
MEDICAL ONCOLOGY (2013)
Cancer metabolism: fatty acid oxidation in the limelight
Arkaitz Carracedo et al.
NATURE REVIEWS CANCER (2013)
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE
Francesca Raimondo et al.
MOLECULAR BIOSYSTEMS (2012)
Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening
Ute Spiekerkoetter
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Network organization of the human autophagy system
Christian Behrends et al.
NATURE (2010)
The molecular determinants of de novo nucleotide biosynthesis in cancer cells
Xuemei Tong et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
Proteomic analysis of liver tissue from HBx-transgenic mice at early stages of hepatocarcinogenesis
Sun-Young Kim et al.
PROTEOMICS (2009)
Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study
Zheng Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
Share Paper
